ADA, antidrug antibody; BP, biopharmaceutical product; IBD, inflammatory bowel disease; IFN, interferon; IL, interleukin; IM, intramuscular; MS, multiple sclerosis; RA, rheumatoid arthritis; SC, subcutaneous; TNF, tumor necrosis factor. This evidence concerns the gene IFNA1 and myeloid sarcoma.